Revenue
2020
2021
2022
2023
2024
2025
BioScience Health Innovations, Inc. (BHIC)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7M | $1.8M | $597,595 | $0 | $0 | $0 |
| Gross profit | $3.2M | $1.3M | $484,407 | — | — | — |
| Research & development | $161,353 | $25,908 | $0 | — | — | — |
| Operating expenses | $2.5M | $1.2M | $735,907 | $91,921 | $25,610 | $7,682 |
| Operating income | $719,051 | $87,000 | −$251,500 | −$91,921 | −$25,610 | −$7,682 |
| Net income | $642,090 | $87,000 | −$251,500 | −$83,208 | −$25,610 | −$7,682 |
| Basic EPSper diluted share | $0.06 | $0.01 | -$0.01 | — | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.06 | $0.01 | -$0.01 | — | $0.00 | $0.00 |